Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 1999 Feb 11;13(2):65–68. doi: 10.1002/(SICI)1098-2825(1999)13:2<65::AID-JCLA4>3.0.CO;2-O

Clinical reliability of IgG, IgA, and IgM antibodies in detecting Epstein‐Barr virus at different stages of infection with a commercial nonrecombinant polyantigenic ELISA

J Gutiérrez 1,, MJ Vergara 1, G Piédrola 1, MC Maroto 1
PMCID: PMC6807699  PMID: 10102134

Abstract

We studied the diagnostic reliability of a modification of the Enzygnost EBV test (Behringwerke, Germany) for the detection of IgG, IgA, and IgM antibodies (Abs) in the diagnosis of Epstein‐Barr virus (EBV) disease. One hundred and twenty‐three serum samples were studied: 14 asymptomatic subjects without EBV infection, 48 patients with primary infection, 46 subjects with past EBV infection (11 patients with other acute infections), 8 patients without EBV infection but with other viral infection, and 7 patients with probable acute clonal stimulation of B lymphocytes caused by different microorganisms. Enzygnost EBV is based on an ELISA test with a pool of viral antigens. In our series the reliability of IgM for the diagnosis of recent primary EBV infection was: sensitivity 100%, specificity 95%, positive predictive value 90.5%, and negative predictive value 100%. The IgG detection with Enzygnost was: sensitivity 98%, specificity 100%, positive predictive value 100%, and negative predictive value 91.7%. Only two subjects had positive IgA. The Enzygnost test is an efficient method for the diagnosis of EBV infection although a few IgM false positives can occur. J. Clin. Lab. Anal. 13:65–68, 1999. © 1999 Wiley‐Liss, Inc.

Keywords: Epstein‐Barr virus, ELISA, antibodies

REFERENCES

  • 1. Henle G, Henle W, Horwitz CA. Antibodies to Epstein‐Barr virus associated nuclear antigen in infectious mononucleosis. J Infect Dis 1974; 130:231–239. Medline [DOI] [PubMed] [Google Scholar]
  • 2. Henle W, Henle GE, Horwitz CA. Epstein‐Barr virus specific diagnostic tests in infectious mononucleosis. Human Pathol, 1974;5:551–565.Medline [DOI] [PubMed] [Google Scholar]
  • 3. Khanna R, Burrows SR, Moss DJ. Immune regulaton in Epstein‐Barr virus‐associated diseases. Microbiol Rev 1995;59:387–405. Medline [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Lennette ET. Epstein‐Barr virus In Lennette EH, editor. Laboratory diagnosis of viral infections, 2nd edition New York: Marcel Dekker; 1992. p 365–380. [Google Scholar]
  • 5. Thorley‐Lawson DA. Basic virologic aspects of Epstein‐Barr virus infection. Semin Hematol 1988;25:247–269. Medline [PubMed] [Google Scholar]
  • 6. Bergman MM, Gleckman RA. Heterophil‐negative infectious mononucleosis‐like syndrome. Postgrad Med J 1987;81:313–326. [DOI] [PubMed] [Google Scholar]
  • 7. Fikar CH, McKee C, Park D. False positivity of IgM antibody to Epstein‐Barr viral capsid antigen during acute hepatitis A infection. Ped Infec Dis J 1994;13:413–414.Medline [DOI] [PubMed] [Google Scholar]
  • 8. Pozetto B, Mbida AD, Grattard F, Bourlet T, Bonnevial L. Comparison of eight commercial tests using Epstein‐Barr (EBV) virus‐specific or nonspecific serology for the diagnosis of infectious mononucleosis (IM). European Group for Rapid Viral Diagnosis, Joint Meeting Prague, PA/66, 1995.
  • 9. Schattner A, Rager‐Zisman B. Virus‐induced autoimmunity. Rev Infect Dis 1990;12:204–222. Medline [DOI] [PubMed] [Google Scholar]
  • 10. Van Grunsven WM, Van Heerde EC, Haard HJW. Gene mapping and expression of two immunodominant Epstein‐Barr virus capsid proteins. J Virol 1993;67:3908–3916. Medline [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Van Grunsven WM, Nabbe A, Middeldorp JM. Identification and molecular characterization of two diagnostically relevant marker proteins of the Epstein‐Barr virus capsid antigen complex . J Med Virol 1993;40:161–169. Medline [DOI] [PubMed] [Google Scholar]
  • 12. De Ory F. Contribution to diagnosis and epidemiology of infections by Epstein‐Barr virus, Cytomegalovirus and Herpes virus Human type 6. University Complutense of Madrid, Doctoral Thesis, 1994.
  • 13. De Ory F, Antonaya J, Fernández MV, Echevarría JM. Application of low‐avidity immunoglobulin G studies to diagnosis of Epstein‐Barr virus infectious mononucleosis. J Clin Microbiol 1993;31:1669–1671. Medline [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Gutiérrez J, Maroto C, Piédrola G. Reliability of four methods for the diagnosis of acute infection by Epstein‐Barr virus. J Clin Lab Anal 1997;11:78–81. Medline [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Gutiérrez J, Rodríguez M, Piédrola G, Peirón J, Maroto C. Behaviour of IgG antibody avidity for the antigen and of IgA antibody in active cytomegalovirus, Epstein‐Barr virus, herpes simplex virus and human herpes virus 6 infections; Adaptation of a commercial test. J Infect 1997;35:25–30. Medline [DOI] [PubMed] [Google Scholar]
  • 16. Färber I, Wutzler P, Wohlrabe P. Serological diagnosis of infectious mononucleosis using three anti‐Epstein‐Barr virus recombinant ELISAs. J Virol Methods 1993;42:301–308. Medline [DOI] [PubMed] [Google Scholar]
  • 17. Gutiérrez J, Maroto C, Piédrola G. Evaluation of a new reagent for anti‐cytomegalovirus and anti‐Epstein‐Barr virus immunoglobulin G. J Clin Microbiol 1994;32:2603–2605. Medline [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Dopatka HD, Schuy W. Compact Epstein‐Barr virus diagnosis based on a defined antigen mix and specific IgA. Res Virol 1996;147:53–66. Medline [DOI] [PubMed] [Google Scholar]
  • 19. Thiele GM. Diagnosis of Epstein‐Barr virus infections in the clinical laboratory. Clin Microbiol News 1993;15:41–46. [Google Scholar]
  • 20. Luka J, Chase RC, Pearson GR. A sensitive enzyme‐linked immunosorbent assay (ELISA) against the major EBV‐associated antigens: Correlation between ELISA and immunofluorescence titers using purified antigens. J Immunol Methods 1984;67:145–156. Medline [DOI] [PubMed] [Google Scholar]
  • 21. Sánchez‐Martínez D, Patton JL, Stewart JA, Pellet PE. Detection of Epstein‐Barr virus‐specific antibodies by means of baculovirus‐expressed EBV gp 125. J Virol Methods 1995;52:145–153. Medline [DOI] [PubMed] [Google Scholar]
  • 22. Gutiérrez J, Piédrola G, Maroto C. Epstein‐Barr virus acute infection: Comparative study between several diagnostic methods . Rev Clin Esp 1992;191:305–307. Medline [PubMed] [Google Scholar]
  • 23. De Ory F. Evaluation of a reagent for the diagnosis of EBV infection. Enferm Infecc Microbiol Clin 1996;14:506–507. Medline [PubMed] [Google Scholar]
  • 24. Gorgievski‐Hrisoho M, Hinderer W, Nebel‐Schickel H. Serodiagnosis of infectious mononucleosis by using recombinant Epstein‐Barr virus antigens and enzyme linked immunosorbent assay technology. J Clin Microbiol 1990;28:23005–23011. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES